A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF-7 breast cancer cells

Breast cancer exhibits the highest incidence of all cancer types and is the 2nd leading cause of cancer mortality in women. Up to 82% of breast cancer patients receive a chemotherapy-containing treatment regimen. However, numerous breast tumors recur within 10 years following an initial response and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommer, Ann-Katrin, Hermawan, Adam, Ljepoja, Bojan, Fröhlich, Thomas, Arnold, Georg J., Wagner, Ernst, Roidl, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108857/
https://www.ncbi.nlm.nih.gov/pubmed/30066829
http://dx.doi.org/10.3892/ijmm.2018.3781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108857/
https://www.ncbi.nlm.nih.gov/pubmed/30066829
http://dx.doi.org/10.3892/ijmm.2018.3781

Ejemplares similares